| (SEK) | Sep 2025 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ACE.ST returned -86.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -80.9% |
| 1 year | -86.8% |
| 5 years | -98.0% |
| All-time high | kr 56.40 (Dec 2020) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in ACE.ST would be worth today ›No. Ascelia Pharma AB (publ) has not paid a dividend in the past 12 months.
Ascelia Pharma AB (publ) is part of the Healthcare sector.
Ascelia Pharma AB (publ) has a market cap of 81.19M SEK, based on the latest quote.
